Immunogenicity of an adjuvanted 2009 pandemic influenza A (H1N1) vaccine in haemodialysed patients

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1424-1428

  Labriola, Laura ^a   Hombrouck, Anneleen ^b   Maréchal, Céline ^a   Van Gucht, Steven ^b   Brochier, Bernard ^b   Thomas, Isabelle ^b   Jadoul, Michel ^a   Goubau, Patrick ^a  

^a CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^b SCIENTIFIC INSTITUTE OF PUBLIC HEALTH   (Belgium)

Author keywords

haemodialysis; immunogenicity; influenza A (H1N1); pandemic influenza A; swine influenza; vaccination

Indexed keywords

INFLUENZA VACCINE;

2009 H1N1 INFLUENZA; ADULT; AGED; ANTIBODY DETECTION; ANTIBODY TITER; ARTICLE; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; ETHNICITY; FEMALE; HEMODIALYSIS PATIENT; HUMAN; IMMUNOGENICITY; INFLUENZA VACCINATION; INJECTION SITE PAIN; MAJOR CLINICAL STUDY; MALE; PANDEMIC INFLUENZA; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; SINGLE DRUG DOSE; TREATMENT RESPONSE;

ADJUVANTS, IMMUNOLOGIC; ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; KIDNEY FAILURE, CHRONIC; MALE; MIDDLE AGED; PANDEMICS; PROGNOSIS; PROSPECTIVE STUDIES; RENAL DIALYSIS; SURVIVAL RATE; VACCINATION; YOUNG ADULT;

EID: 79953892773     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq782     Document Type: Article

References (17)

1. World Health OrganizationInfluenza-like Illness in the United States and Mexico 2009http://www.who.int/csr/don/2009-04-24/en/index. html (6 October 2010, date last accessed)
2. World Health OrganizationDG Statement Following the Meeting of the Emergency Committee http://www.who.int/csr/disease/swineflu/ 4th-meeting-ihr/en/index.html (6 October 2010, date last accessed)
3. World Health Organization2009 Characteristics of the Emergent Influenza A (H1N1) Viruses and Recommendations for Vaccine Development http://www.who.int/ csr/resources/publications/swineflu/ H1N1Vaccinevirusrecommendation26May2009.pdf (6 October 2010, date last accessed)
4. Centers for Disease Control and Prevention2009 H1N1 Vaccination Recommendations www.cdc.gov/H1N1flu/vaccination/acip/htm (6 October 2010, date last accessed)
5. European Centre for Disease Prevention and ControlUse of Specific Pandemic Influenza Vaccines During the H1N1 2009 Pandemic 2009http://www. reliefweb.int/rw/RWFiles2009.nsf/FilesByRWDocU-nidFilename/ASHU-7UW2MM-full- report.pdf/$File/full-report.pdf (2 November 2011, date last accessed)
6. Clark TW, Pareek M, Hoschler K et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. N Engl J Med 2009; 361: 2424-2435
7. Greenberg ME, Lai MH, Hartel GF et al. Response to a monovalent 2009 influenza A (H1N1) vaccine.N Engl J Med 2009; 361: 2405-2413
8. Zhu FC, Wang H, Fang HH et al. A novel influenza A (H1N1) vaccine in various age groups. N Engl J Med 2009; 361: 2414-2423
9. Marcelli D, Marelli C, Richards N. Influenza A (H1N1)v pandemic in the dialysis population: first wave results from an international survey. Nephrol Dial Transplant 2009; 24: 3566-3572
10. Rowe T, Abernathy RA, Hu-Primmer J et al. Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic tests. J Clin Microbiol 1999; 37: 937-943 (Pubitemid 29140593)
11. Labriola L, Jadoul M. The decades-long fight against HBV transmission to dialysis patients: slow but definite progress. Nephrol Dial Transplant 2010; 25: 2047-2049
12. Janus N, Vacher LV, Karie S et al. Vaccination and chronic kidney disease. Nephrol Dial Transplant 2008; 23: 800-827
13. Schroth RJ, Hitchon CA, Uhanova J et al. Hepatitis B vaccination for patients with chronic renal failure. Cochrane Database Syst Rev 2004; 3: CD003775
14. Surquin M, Tielemans CL, Kulcsar I et al. Rapid, enhanced, and persistent protection of patients with renal insufficiency by AS02(V)-ad-juvanted hepatitis B vaccine. Kidney Int 2010; 77: 247-55
15. Kong NCT, Beran J, Kee SA et al. Immunogenicity and safety of an adjuvanted hepatitis B vaccine in pre-hemodialysis and hemodialysis patients. Kidney Int 2005; 68: 2298-303 (Pubitemid 43117807)
16. ScharpéJ, Peetermans WE, VanwalleghemJet al. Immunogenicityofa standard trivalent influenza vaccine in patients on long-term hemodialysis: an open-label trial. Am J Kidney Dis 2009; 54: 77-85
17. Hancock K, Veguilla V, Lu X et al. Cross-reactive antibody responses to the 2009 pandemic H1N1 influenza virus. N Engl J Med 2009; 361: 1945-1952